Zobrazeno 1 - 10
of 320
pro vyhledávání: '"innovative medicines"'
Autor:
Margherita d’Errico, Diana Giannarelli, Daniela d’Angela, Carmine Pinto, Barbara Polistena, Federico Spandonaro
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 17, Iss 1 (2024)
Introduction Considering the clinical impact of innovative cancer therapies, policy makers strive to balance timely access and thorough value-assessment. While some European countries promoted early access schemes, Italy does not yet display a consol
Externí odkaz:
https://doaj.org/article/3dc64b1079964c529cf2821951050305
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
The pharmaceutical medicine course at the Semmelweis University of Budapest, Hungary, was initiated as part of the Innovative Medicines Initiative (IMI is the main program, IMI-PharmaTrain is one of the IMI projects) Pharmaceutical Medicine Training
Externí odkaz:
https://doaj.org/article/3019060f163149b5b277632d7ab87663
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 13, Iss 3 (2024)
In this latest update, we explore some of the key updates in market access over recent months including the UK’s voluntary scheme for branded medicines pricing, access and growth (VPAG), the first drugs funded by the Innovative Medicines Fund in th
Externí odkaz:
https://doaj.org/article/afc97ac51a8b48b398a9a27ebcce3c5c
Autor:
Angela Bradshaw, Nigel Hughes, David Vallez-Garcia, Davit Chokoshvili, Andrew Owens, Clint Hansen, Kirsten Emmert, Walter Maetzler, Lewis Killin, Rodrigo Barnes, Anthony J. Brookes, Pieter Jelle Visser, Martin Hofmann-Apitius, Carlos Diaz, Lennert Steukers
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
Efficient data sharing is hampered by an array of organizational, ethical, behavioral, and technical challenges, slowing research progress and reducing the utility of data generated by clinical research studies on neurodegenerative diseases. There is
Externí odkaz:
https://doaj.org/article/e12f29d75f1f4dc4ad0dcd9b1a9f2391
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
The Innovative Medicines Initiative (IMI), was a European public–private partnership (PPP) undertaking intended to improve the drug development process, facilitate biomarker development, accelerate clinical trial timelines, improve success rates, a
Externí odkaz:
https://doaj.org/article/22db6045dc8842728e71bab27b3e5ee3
Autor:
Robbe Saesen, Matilde Machado, Bianca Crifo, Lifang Liu, Corinne de Vries, Ralf Herold, Jordi Llinares Garcia, Isabelle Huys
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
BackgroundThe European Medicines Agency (EMA) interacts with many different stakeholders involved in the development of drugs, including academic researchers. In recent years, EMA has collaborated more closely with academia, inter alia by taking part
Externí odkaz:
https://doaj.org/article/ec20d80ae9b94c39b26358493e16d82c
Autor:
Claire Hawksworth, Fatima Salih, Katharine Cresswell, Lennert Steukers, Carlos Diaz, Lewis Killin, Laurent Pradier, Angela Bradshaw, Dalia Dawoud
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
The European Commission's Innovative Medicines Initiative (IMI) has funded many projects focusing on neurodegenerative disorders (ND) that aimed to improve the diagnosis, prevention, treatment and understanding of NDs. To facilitate collaboration acr
Externí odkaz:
https://doaj.org/article/324888d23cb64b639698dcdb7b88bd0f
Publikováno v:
Фармакоэкономика, Vol 15, Iss 1, Pp 87-105 (2022)
Objective: to assess the compliance of the actual practice of conducting clinical and economic research with the requirements applicable in the Russian Federation (RF) when including drugs in the Federal Program of High-Cost Nosologies (HCN).Material
Externí odkaz:
https://doaj.org/article/411137fa18374be49b88cd7009aea2a7
Autor:
Stina Saunders, Sarah Gregory, Matthew H. S. Clement, Cindy Birck, Serge van der Geyten, Craig W. Ritchie
Publikováno v:
Frontiers in Neurology, Vol 13 (2022)
IntroductionTens of millions of people worldwide will develop Alzheimer's disease (AD), and only by intervening early in the preclinical disease can we make a fundamental difference to the rates of late-stage disease where clinical symptoms and socie
Externí odkaz:
https://doaj.org/article/44f5c9f48060460d82ca6dc0d2155001
International Collaboration and the Information Technology That Fuels It : Keys to a Brighter Future
Autor:
Hammitt, Katherine M., author
Publikováno v:
The Sjögren's Book, 2022.
Externí odkaz:
https://doi.org/10.1093/oso/9780197502112.003.0051